• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术时机与早期肺癌患者结局的关联。

Association of Surgical Timing with Outcomes in Early Stage Lung Cancer.

机构信息

Department of Surgery, UCSF East Bay, 1411 E 31St St, Oakland, CA, 94602, USA.

Department of Thoracic Surgery, Kaiser Permanente Northern California, 3600 Broadway, Oakland, CA, 94611, USA.

出版信息

World J Surg. 2023 May;47(5):1323-1332. doi: 10.1007/s00268-023-06913-w. Epub 2023 Jan 25.

DOI:10.1007/s00268-023-06913-w
PMID:36695837
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10070299/
Abstract

BACKGROUND

Optimal time to surgery for lung cancer is not well established. We aimed to assess whether time to surgery correlates with outcomes.

METHODS

We assessed patients 18-84 years old who were diagnosed with stage I/II lung cancer at our integrated healthcare system from 2009 to 2019. Time to surgery was defined to start with disease confirmation (imaging or biopsy) prior to the surgery scheduling date. Outcomes of unplanned return to care within 30 days of lung cancer surgery, all-cause mortality, and disease recurrence were compared based on time to surgery before and after 2, 4, and 12 weeks.

RESULTS

Of 2861 included patients, 70% were over 65 years old and 61% were female. Time to surgery occurred in 1-2 weeks for 6%, 3-4 weeks for 31%, 5-12 weeks for 58%, and 13-26 weeks for 5% of patients. Patients with time to surgery > 4 (vs. ≤ 4) weeks had greater risk of both death (hazard ratio (HR) 1.18, 95% confidence interval (CI) 1.00-1.39) and recurrence (HR 1.33, 95% CI 1.10-1.62). Associations were not statistically significant when dichotomizing time to surgery at 2 or 12 weeks for death (2 week HR 1.23, 95% CI 0.93-1.64; 12 week HR 1.35, 95% CI 0.97-1.88) and recurrence (2 week HR 1.54, 95% CI 0.85-2.80; 12 week HR 2.28, 95% CI 0.80-6.46).

CONCLUSIONS

Early stage lung cancer patients with time to surgery within 4 weeks experienced lower rates of recurrence. Optimal time to surgical resection may be shorter than previously reported.

摘要

背景

肺癌的最佳手术时机尚未确定。我们旨在评估手术时间是否与结局相关。

方法

我们评估了 2009 年至 2019 年在我们的综合医疗系统中被诊断为 I/II 期肺癌的 18-84 岁患者。手术时间定义为从手术安排日期之前的疾病确诊(影像学或活检)开始。根据手术前 2、4 和 12 周的时间,比较肺癌手术后 30 天内无计划返回治疗、全因死亡率和疾病复发的结果。

结果

在 2861 名纳入患者中,70%的患者年龄超过 65 岁,61%的患者为女性。手术时间为 1-2 周的患者占 6%,3-4 周的患者占 31%,5-12 周的患者占 58%,13-26 周的患者占 5%。手术时间大于 4 周(与小于等于 4 周相比)的患者死亡(风险比(HR)1.18,95%置信区间(CI)1.00-1.39)和复发(HR 1.33,95%CI 1.10-1.62)的风险更高。当将手术时间在 2 周或 12 周时分为死亡(2 周 HR 1.23,95%CI 0.93-1.64;12 周 HR 1.35,95%CI 0.97-1.88)和复发(2 周 HR 1.54,95%CI 0.85-2.80;12 周 HR 2.28,95%CI 0.80-6.46)时,相关性没有统计学意义。

结论

手术时间在 4 周内的早期肺癌患者复发率较低。手术切除的最佳时间可能比之前报道的更短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f571/10070299/53eb4bcfc1d9/268_2023_6913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f571/10070299/53eb4bcfc1d9/268_2023_6913_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f571/10070299/53eb4bcfc1d9/268_2023_6913_Fig1_HTML.jpg

相似文献

1
Association of Surgical Timing with Outcomes in Early Stage Lung Cancer.手术时机与早期肺癌患者结局的关联。
World J Surg. 2023 May;47(5):1323-1332. doi: 10.1007/s00268-023-06913-w. Epub 2023 Jan 25.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.临床Ⅰ期非小细胞肺癌延迟手术治疗与肿瘤学结局分析。
JAMA Netw Open. 2021 May 3;4(5):e2111613. doi: 10.1001/jamanetworkopen.2021.11613.
4
Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatment.口腔和口咽癌的治疗干预措施:手术治疗。
Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD006205. doi: 10.1002/14651858.CD006205.pub5.
5
Oncoplastic breast-conserving surgery for women with primary breast cancer.原发性乳腺癌患者的肿瘤整形保乳手术。
Cochrane Database Syst Rev. 2021 Oct 29;10(10):CD013658. doi: 10.1002/14651858.CD013658.pub2.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.对局部晚期宫颈癌女性患者进行子宫切除术并辅以放疗或化疗或两者联合治疗。
Cochrane Database Syst Rev. 2015 Apr 7(4):CD010260. doi: 10.1002/14651858.CD010260.pub2.
8
Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.早期上皮性卵巢癌的辅助(术后)化疗。
Cochrane Database Syst Rev. 2012 Mar 14;3(3):CD004706. doi: 10.1002/14651858.CD004706.pub4.
9
Treatment for women with postpartum iron deficiency anaemia.产后缺铁性贫血女性的治疗。
Cochrane Database Syst Rev. 2024 Dec 13;12(12):CD010861. doi: 10.1002/14651858.CD010861.pub3.
10
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.用于经手术或根治性放疗治疗的Ⅰ至Ⅲ期非小细胞肺癌的免疫疗法(不包括检查点抑制剂)。
Cochrane Database Syst Rev. 2017 Dec 16;12(12):CD011300. doi: 10.1002/14651858.CD011300.pub2.

引用本文的文献

1
Racial/Ethnic Disparities in Lung Cancer Surgery Outcomes in the USA.美国肺癌手术结果中的种族/民族差异。
Epidemiologia (Basel). 2025 Apr 11;6(2):18. doi: 10.3390/epidemiologia6020018.
2
Video-Assisted vs Robotic-Assisted Lung Lobectomies for Operating Room Resource Utilization and Patient Outcomes.电视辅助与机器人辅助肺叶切除术对手术室资源利用及患者预后的影响
JAMA Netw Open. 2024 May 1;7(5):e248881. doi: 10.1001/jamanetworkopen.2024.8881.
3
Impact of time-to-treatment initiation on survival in single primary non-small cell lung Cancer: A population-based study.

本文引用的文献

1
Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.非小细胞肺癌,2022年第3版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2022 May;20(5):497-530. doi: 10.6004/jnccn.2022.0025.
2
How Much Delay Matters? How Time to Treatment Impacts Overall Survival in Early Stage Lung Cancer.治疗时间延迟多久会产生影响?早期肺癌的整体生存与治疗时间的关系。
Ann Surg. 2023 Apr 1;277(4):e941-e947. doi: 10.1097/SLA.0000000000005307. Epub 2021 Nov 18.
3
Diagnosis-to-surgery interval and survival for different histologies of stage I-IIA lung cancer.
单发性原发性非小细胞肺癌治疗开始时间对生存的影响:一项基于人群的研究。
Heliyon. 2023 Sep 2;9(9):e19750. doi: 10.1016/j.heliyon.2023.e19750. eCollection 2023 Sep.
I-IIA期肺癌不同组织学类型的诊断至手术间隔时间与生存率
Transl Lung Cancer Res. 2021 Jul;10(7):3043-3058. doi: 10.21037/tlcr-21-168.
4
Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.非小细胞肺癌的治疗时间与结局的相关性:一项系统综述。
Thorax. 2022 Aug;77(8):762-768. doi: 10.1136/thoraxjnl-2021-216865. Epub 2021 Aug 17.
5
Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.临床Ⅰ期非小细胞肺癌延迟手术治疗与肿瘤学结局分析。
JAMA Netw Open. 2021 May 3;4(5):e2111613. doi: 10.1001/jamanetworkopen.2021.11613.
6
Effect of thoracic surgery regionalization on long-term survival after lung cancer resection.胸外科区域化对肺癌切除术后长期生存的影响。
J Thorac Cardiovasc Surg. 2022 Mar;163(3):769-777. doi: 10.1016/j.jtcvs.2021.03.050. Epub 2021 Mar 20.
7
Estimating the Impact of Extended Delay to Surgery for Stage I Non-small-cell Lung Cancer on Survival.评估 I 期非小细胞肺癌手术延迟对生存的影响。
Ann Surg. 2021 May 1;273(5):850-857. doi: 10.1097/SLA.0000000000004811.
8
Impact of time-to-treatment on overall survival of non-small cell lung cancer patients-an analysis of the national cancer database.治疗时间对非小细胞肺癌患者总生存期的影响——一项基于国家癌症数据库的分析
Transl Lung Cancer Res. 2020 Aug;9(4):1202-1211. doi: 10.21037/tlcr-19-675.
9
Regionalization of Lung Cancer Surgery Improves Outcomes in an Integrated Health Care System.肺癌手术的区域化提升了综合医疗体系的治疗效果。
Ann Thorac Surg. 2020 Jul;110(1):276-283. doi: 10.1016/j.athoracsur.2020.02.019. Epub 2020 Mar 14.
10
Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy.适合根治性治疗的肺癌退伍军人的治疗时间和生存情况。
Respir Med. 2018 Aug;141:172-179. doi: 10.1016/j.rmed.2018.07.005. Epub 2018 Jul 17.